Related Experiment Video

Updated: Apr 3, 2026

Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity
12:52

Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity

Published on: March 5, 2020

9.0K

Imaging alterations of cardiomyocyte cAMP microdomains in disease

Alexander Froese1, Viacheslav O Nikolaev2

  • 1Department of Cardiology and Pulmonology, Heart Research Center Göttingen, Georg August University Medical Center , Göttingen, Germany.

Frontiers in Pharmacology
|September 18, 2015
PubMed

Insights

Cyclic adenosine monophosphate (cAMP) signaling in heart cells is crucial for cardiac function. This review details how altered cAMP microdomains in heart disease, like hypertrophy and heart failure, impact cardiovascular health.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cell Biology
  • Biochemistry

Background:

  • 3',5'-cyclic adenosine monophosphate (cAMP) acts as a vital second messenger regulating cardiomyocyte function.
  • Compartmentalized cAMP signaling within subcellular microdomains is essential for precise control of heart activity.
  • Dysregulation of cAMP signaling is implicated in various cardiac pathologies.

Purpose of the Study:

  • To review recent advancements in understanding compartmentalized cAMP signaling in the heart.
  • To synthesize current knowledge on alterations in cardiomyocyte cAMP microdomains during cardiac hypertrophy and heart failure.
  • To discuss future research avenues and translational applications in cardiac disease.

Main Methods:

  • Literature review of cutting-edge biochemical and biophysical techniques.
  • Compilation and synthesis of data from diverse studies on cAMP signaling.
  • Analysis of alterations in cardiomyocyte cAMP microdomains in disease models.

Main Results:

  • Recent studies have elucidated intricate mechanisms of compartmentalized cAMP signaling.
  • Specific alterations in cardiomyocyte cAMP microdomains are identified in compensated cardiac hypertrophy and chronic heart failure.
  • These microdomain changes represent a significant factor in the progression of cardiac disease.

Conclusions:

  • Compartmentalized cAMP signaling is a key determinant of cardiac function and disease.
  • Understanding alterations in cardiomyocyte cAMP microdomains offers insights into cardiac pathophysiology.
  • Further research and therapeutic strategies targeting cAMP signaling hold translational potential for heart disease treatment.
Keywords:
FRETbiosensorcAMPcardiomyocyteheart failurehypertrophymicrodomain

More Related Videos

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.9K
Visualization of Cell Cycle Variations and Determination of Nucleation in Postnatal Cardiomyocytes09:41

Visualization of Cell Cycle Variations and Determination of Nucleation in Postnatal Cardiomyocytes

Published on: February 24, 2017

9.2K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
769
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
818
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
830